Is your melanoma hot enough for immunotherapy?

(University of Colorado Anschutz Medical Campus) University of Colorado Cancer Center study presented at AACR 2019 shows that tumors with mutations in genes leading to over-activation of the NF-kB signaling pathway were more than three times as likely to respond to anti-PD1 immunotherapy compared with tumors in which these changes were absent.

https://www.eurekalert.org/pub_releases/2019-04/uoca-iym040219.php

Source: EurekAlert! - Cancer - April 2, 2019 Category: Cancer & Oncology Source Type: news